HC Hoagland

1.8k citations
15 papers · 765 indexed · h-index 8
Topics
Acute Myeloid Leukemia Research (6 papers)Chronic Lymphocytic Leukemia Research (6 papers)Lymphoma Diagnosis and Treatment (4 papers)
Partner nations
United States

In The Last Decade

HC Hoagland

15 papers receiving 715 citations

Peers

HC Hoagland
Comparison fields: 5 of 71
  • Hematology 538
  • Genetics 245
  • Molecular Biology 203
  • Oncology 165
  • Public Health, Environmental and Occupational Health 152
Replace Moore Ma with:
Moore Ma United States
Muhammad Shurafa United States
Esperanza Such Spain
Su‐Peng Yeh Taiwan
Chi‐Fei Huang Taiwan
Kazuo Tsubaki Japan
Mohamed Elhamri France
M. Schoester Netherlands
Yasunobu Sakai United States
Yoshiaki Okuno Japan
HC Hoagland relative to Moore Ma United States Moore Ma's profile →
Citations per field
00.5×
Moore Ma · 1×
Citations per year

Countries citing papers authored by HC Hoagland

Since Specialization
Citations

This map shows the geographic impact of HC Hoagland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HC Hoagland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HC Hoagland more than expected).

Fields of papers citing papers by HC Hoagland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HC Hoagland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HC Hoagland. The network helps show where HC Hoagland may publish in the future.

Co-authorship network of co-authors of HC Hoagland

This figure shows the co-authorship network connecting the top 25 collaborators of HC Hoagland. A scholar is included among the top collaborators of HC Hoagland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HC Hoagland. HC Hoagland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 6
2 6
3 66
4 73
5
Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
33
6
Efficacy and safety of recombinant human erythropoietin r huepo in anemic patients with myelodysplastic syndromes
6
7 225
8 3
9 81
10
Hematologic complications of cancer chemotherapy.
147
11
Treatment of adult acute lymphocytic leukemia.
4
12 7
13 63
14 6
15
45,X cell lines in adult men: loss of Y chromosome, a normal aging phenomenon?
39

About HC Hoagland

HC Hoagland is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 15 papers that have together received 765 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (538 citations), Genetics (245 citations) and Oncology (165 citations). HC Hoagland has collaborated with scholars based in United States. Frequent co-authors include GW Dewald, M. N. Silverstein, Robert W. Carey, Jeffrey J. Kirshner, Harvey D. Preisler, Philip Schulman, RB Davis, Fred Richards, RN Levy and Samuel Kopel. Their work appears in journals such as Blood, Mayo Clinic Proceedings and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026